Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Mansoura University: Clinical Trials & FDA Approval Profile

Mansoura University (Global / Institutional) sponsors 92 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 26 active protocols (14 recruiting now), 24 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)1.1%
Median Closed Enrollment vs National (145 pts)70 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Mansoura University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)92
Active Pipeline (Recruiting Now)26 (14)
Completed vs Stopped Early24 / 1 (1.1%)
Median Closed Actual Enrollment70 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Explore interactive annual charts and M&A subsidiary rollups in the Mansoura University Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI